Influenza Flashcards

1
Q

How does influenza related to the sun?

A

More severe epidemics of influenza occur every 11 years; same as increased ‘sunspot activity’

The sun’s radiation may cause mutations leading to “antigenic shifts’ in viral RNA.

Theory that Vitamin D levels help to prevent viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the structure of influenza?

A
  • RNA virus. 8 segment genome
  • Orthomyxoviridae family
  • Three main groups:
  • A (1933)
  • B (1939)
  • C (1950)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

INfluenza A, B and C affect whoa dn what?

A

IfA infects mammals and birds, IfB & IfC only humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the surface proteins of influenza and their function?

A

18 different H antigens (H1-3 in humans) and 11 different N antigens

Haemagglutinin (H) - facilitates viral attachment and entry to host cell

Neuraminidase (N) - enables new virion to be released from host cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is antigenic drift?

A
  • Mechanism of genetic variation within the virus
  • Occurs continually over time, small on-going point mutations in the genes coding for antibody binding-sites
  • May change the antigenic properties and eventually the immune system will not combat the virus as well
  • Causes worse than normal epidemics & vaccine mismatch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is antigenic shift?

A
  • Abrupt major change in the virus, resulting in new H/N combinations
  • The genetic change that enables a flu strain to jump from one animal species to another
  • The process by which two or more different strains of a virus combine to form a new subtype, resulting in new H/N combinations
  • Reassortment of the virus’ gene segments
  • With new antigenic properties the population at risk is unprotected and this can lead to PANDEMICS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between antigenic drift and shift?

A

Antigenic drift - Mutations causing minute changes in the hemagglutinin and neuraminidase antigens on the surface of the Influenza virus is termed as antigenic drift

Antigenic shift - Antigenic shift refers to the gene recombination occurring when influenza viruses re-assort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is pandemic flu different form seasonal flu?

A

Seasonal flu:

  • Occurs every winter
  • Affects 10-15 % of the population
  • Usually unpleasant but not life-threatening

Pandemic flu:

  • Occur sporadically
  • Affects 25% + of the population
  • More serious, more complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the requirements for a pandemic?

A

Human pathogenicity

‘New’ virus (antigenic shift) - susceptible population

Efficient person-person transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what age has the greatest mortality?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is avian flu?

A
  • Many types of avian influenza - Few strains affect humans: H5N1 (since 1997), H7N9 (since 2013)
  • Spreads through direct contact with infected birds, dead or alive
  • Occasional transmission via close human to human contact (staff, caregivers)
  • No known transmission by eating properly cooked food/eggs etc
  • High case fatality rate: 60% (H5N1), 36% (H7N9)
  • Current outbreaks in China (H7N9) and Egypt (H5N1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the clinical features of influenza?

A
  • Incubation period 2-4 days (range 1-7 days)
  • Abrupt fever up to 41°C (commonly 38-40°C) which lasts 3 days (range 1-5 days)
  • Plus 2 or more of: Cough, [sore throat, rhinorrhoea], myalgia, headache, malaise.
  • Predominance of systemic symptoms
  • Less common symptoms: Nausea, vomiting, diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Influenza like illness (ILI)

WHO definition (2011); for epidemiological purpose is what?

A
  • Fever (>38°C) and
  • Cough
  • Onset within the last 10 days

(if requires hospitalization defined as severe acute respiratory infection (SARI))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the symptoms of swine flu?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is it transmitted?

A
  • Airborne - person = person by large droplets >5 microns
  • Contact – direct (person = person)

– indirect (person = fomite = person)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is virus shedding?

A

viral shedding occurs when a virus replicates inside your body and is released into the environment. at that point, it may be contagious

17
Q

what is the virus shedding of this infection?

A

• First 4 days of illness (range 1-7 days)

Longer in young children & immunocompromised

18
Q

what is the virus survival?

A
  • 24-48 hours on non-porous surfaces
  • 8-12 hours on porous surface e.g. tissue
19
Q

high risk groups:

What are some risk factors for complicated influenza?

A

a. Neurological, hepatic, renal, pulmonary and chronic cardiac disease
b. Diabetes mellitus
c. Severe immunosuppression
d. Age over 65 years
e. Pregnancy (including up to two weeks post partum)
f. Children under 6 months of age
g. Morbid obesity (BMI ≥40)

20
Q

what are some common respiratory complications?

A
  • Acute Bronchitis
  • Secondary Bacterial Pneumonia (~20%) - Appears 4-5 days after start of ‘flu
21
Q

What are some Less Common respiratory Complications?

A

• Primary viral pneumonia

  • appears common in human cases of avian influenza (H5N1)
  • rapid respiratory failure; within 48 hours
  • mortality >40%; within 7 days
22
Q

what are some less common cardiac complications?

A

Myocarditis/pericarditis

23
Q

What are some less common CNS complications?

A
  • Transverse myelitis/Guillain-Barre
  • Myositis & Myoglobinuria
24
Q

influenza is a ____________ disorder

A

multi-system

25
Q

what is the diagnosis and investigations required?

A
  • Viral nose and throat swabs/VTS (Molecular detection /PCR; using flocked swabs)
  • Chest X-ray – pneumonitis/pneumonia/ARDS
  • Blood culture
  • Pulse oximetry – SpO2 <92% need ABG and oxygen
  • Respiratory rate !
  • U & E’s, FBC, CRP (CRP monitoring recovery of pneumonia - should halve in 4 days)
26
Q

what is secondary bacterial pneumonia and what needs to be done?

A
  • Patients with ‘flu symptoms and a fever for > 4days – should have an urgent CXR
  • Severity assessment – use C(U)RB-65 score
  • Confusion
  • Urea >7mmol/l
  • Respiratory rate >30mm
  • Blood Pressure (diastolic <60 or systolic <90)
  • >65 years of age

• C(U)RB score: Risk of death in the next 30 days (0=0.6%, 1=3.2%, 2=13%, 3=17%, 4=41.5%, 5=57%)

27
Q

should you use antiviral therapy?

A

Use ASAP and within 48hours of symptom onset!

28
Q

what antiviral treatments are there avalible?

A

OSELTAMIVIR (TAMIFLU) - Oral

Dose : Over 13 years – 75mg every 12 hours for 5 days

Adverse Effects:

Common – Nausea, vomiting, abdominal pain, diarrhoea

Less Common – Headache, hallucinations, insomnia and rash

Cautions: Renal dosing needed

ZANAMIVIR (RELENZA) – Inhaled & or I.V.

Available only as a dry powder inhaler

Dose: Over 12 years – 10mg inhaled daily for up to 10 days

Adverse Effects: Rare – occasional bronchospasm

29
Q

what are some other antiviral therapies?

A

•Peramivir (Alpivab®)

–Neuroaminidase inhibitor

–Licensed in USA and approved by European Medicines Agency (EMA) 1st May 2018 !

–Intravenous infusion, for uncomplicated influenza

• Favipiravir (Avigan®, Toyama Chemicals Ltd)

–Viral RNA polymerase inhibitor

–Licenced in Japan for ‘re-emerging influenza viruses’

–Oral medication

• Baloxavir Marboxil (Xofluza®, Roche)

–Endonuclease inhibitor

–One single dose

•(Amantadine & Rimantadine not used due to resistance)

30
Q

what are the current guidelines for antiviral therapy in pregnancy?

A

Antivirals have been recommended…due to the adverse outcomes …in this group

Oseltamivir remains first line option…

Recent studies (2014) suggests there is no evidence of harm of either oseltamivir or zanamivir

FDA pregnancy category C: No malformation, maternal toxicity or embryotoxcity were observed in animal studies. No data available in humans.

31
Q

Antiviral therapy and breastfeeding

A
  • Only tiny amounts of Oseltamivir in milk
  • Current guidance is – Oral Oseltamivir
32
Q

When does an individual become non-infectious?

A

IMMUNOCOMPETENT ADULTS

  • 24hrs after last flu symptoms (fever & cough)
  • Or when anti-viral therapy completed, Which ever is longer

IMMUNOCOMPROMISED ADULTS & YOUNG CHILDREN

•Consider each case separately

33
Q

what protection is required for healthcare staff?

A
  • Surgical face mask
  • Plastic apron
  • Gloves

Wash hands after any examination

34
Q

what is the vaccine prepared and given? (seasonal flu vaccine)

A
  • Prepared each year using viruses considered most likely to be circulating in the forthcoming winter
  • Grown in chick embryos (therefore C.I. in those with egg allergy)
  • Chemically inactivated and purified, trivalent vaccines - Containing 2 type A & 1 type B subtype viruses
  • Single 0.5 ml intramuscular injection
  • Only adverse effect in large placebo controlled trials is sore arm
35
Q

why should healthcare workers have the vaccine?

A
  • To protect themselves and their families
  • To reduce the risk to ‘at risk’ patients
  • To reduce absence from work during influenza ‘surge’ activity